Evotec
Martin Alexi is currently working at Evotec as a Group Lead Strategic Buyer GER/AUT since June 2023. Prior to this, Martin held various senior management positions at Nordex / Acciona Windpower for over 15 years, including roles such as Senior After Sales Manager, Global Service, Contract Sales Manager, Head of China Sourcing, Strategic Lead Buyer, and Operative Buyer/ Materials Manager. Before joining Nordex, Martin was a Key-Account-Manager at Brüggen GmbH from 2005 to 2008.
This person is not in any teams
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.